[GENERAL PHARMACOLOGIC CHARACTERISTICS OF A NEW POTENT ANTI-INFLAMMATORY AGENT, 2-(BETA-CHLOROETHYL)-2,3-DIHYDRO-4-KETO-6-AMINO-(BENZO-1,3-OXAZINE) HCL (ICI 350)].
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D006801:Humans; D051379:Mice; D010078:Oxazines; D010600:Pharmacology; D051381:Rats; D012106:Research; D014116:Toxicology
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D010078:Oxazines
ANALGESICS AND ANTIPYRETICS; EXPERIMENTAL LAB STUDY; MICE; PHARMACOLOGY; RATS; TOXICOLOGIC REPORT
CARATTERISTICHE FARMACOLOGICHE GENERALI DI UN NUOVO POTENTE ANTIFLOGISTICO, IL CLORIDRATO DELLA 2-(BETA-CLOROETIL)-2,3-DIIDRO-4-CHETO-6-AMINO-(BENZO-1,3-OSSAZINA) (ICI 350)